{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-26-025474","form_type":"8-K","ticker":"MBRX","cik":"0001659617","company_name":"Moleculin Biotech, Inc.","filed_at":"2026-08-03T21:11:51+00:00","discovered_at":"2026-08-03T21:14:00.423361+00:00","generated_at":"2026-08-03T21:14:12.462857+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Moleculin Biotech raises ~$9.3M in public offering of common stock and warrants","bullets":["Gross proceeds of ~$9.3M from sale of 12.4M shares and warrants at $0.75 per unit.","Warrants exercisable at $0.75 for five years; pre-funded warrants at $0.001.","Proceeds to fund Annamycin clinical development and working capital.","Lock-up agreements for officers/directors for 60 days; 45-day ban on further equity issuances.","Placement agent fees: 6.5% to Roth Capital, 1% to Maxim Group."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-025474","json":"https://secwatch.observer/filing/0001437749-26-025474.json","markdown":"https://secwatch.observer/filing/0001437749-26-025474.md","text":"https://secwatch.observer/filing/0001437749-26-025474.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1659617/000143774926025474/0001437749-26-025474-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1659617/000143774926025474/mbrx20260803_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-03T21:14:12.462857+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}